ITERUM THERAPEUTICS PLC's ticker is ITRM and the CUSIP is G6333L101. A total of 21 filers reported holding ITERUM THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,339,000 | -14.2% | 396,385 | 0.0% | 0.14% | -9.6% |
| Q2 2019 | $2,727,000 | -14.7% | 396,385 | -0.5% | 0.16% | -27.3% |
| Q1 2019 | $3,198,000 | +37.0% | 398,300 | -14.5% | 0.22% | +13.7% |
| Q4 2018 | $2,335,000 | -26.9% | 466,002 | -2.3% | 0.19% | -8.7% |
| Q3 2018 | $3,196,000 | -41.3% | 476,968 | -4.6% | 0.21% | -48.4% |
| Q2 2018 | $5,445,000 | – | 500,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 1,733,170 | $4,003,000 | 6.01% |
| New Leaf Venture Partners, L.L.C. | 1,456,303 | $2,729,000 | 0.70% |
| Focused Wealth Management, Inc | 100,000 | $231,000 | 0.04% |
| FineMark National Bank & Trust | 300,000 | $693,000 | 0.03% |
| Virtu Financial LLC | 83,658 | $193,000 | 0.02% |
| GRIMES & COMPANY, INC. | 146,278 | $338,000 | 0.02% |
| QS Investors, LLC | 384,200 | $888,000 | 0.01% |
| Insight Advisors, LLC/ PA | 35,000 | $28,000 | 0.01% |
| Renaissance Technologies | 3,289,300 | $7,598,000 | 0.01% |
| Krilogy Financial LLC | 31,000 | $72,000 | 0.01% |